# Problem Specification

> Grounding: abstract-only. Observations are limited to statements in `metadata.md` and `metadata.json`.

## Observations

### O01: Alzheimer disease and other dementias are a growing global health issue
- **Statement**: The abstract identifies Alzheimer disease as a growing global health issue with incidence varying by gender, age, and region.
- **Evidence**: metadata.md abstract, Background.
- **Implication**: Incidence patterns need to be analyzed across demographic and geographic strata, not only at the global aggregate level.

### O02: Prior GBD studies emphasized other burden measures
- **Statement**: The abstract says previous GBD studies primarily focused on prevalence and mortality rather than historical incidence trends and future incidence projections.
- **Evidence**: metadata.md abstract, Background.
- **Implication**: An incidence-centered analysis can add a perspective not provided in the original GBD datasets or their supplements.

### O03: Global cases rose while global ASIR changed only slightly
- **Statement**: Between 1992-2021, global AD cases increased from 4.078 million to 9.837 million, while ASIR rose from 117.7 to 119.8 per 100,000.
- **Evidence**: metadata.md abstract, Results.
- **Implication**: Absolute case burden and age-standardized incidence trends can diverge, consistent with demographic expansion and ageing effects.

### O04: Incidence trends differed by SDI region and sex
- **Statement**: ASIR increased significantly in high-middle and middle-SDI regions, declined in low-SDI regions, and women had higher incidence rates than men across all regions.
- **Evidence**: metadata.md abstract, Results.
- **Implication**: Global averages mask region- and sex-specific incidence patterns.

### O05: Future projections report continued growth
- **Statement**: The abstract projects 2036 global AD cases of 19.117 million and ASIR of 418.92 per 100,000.
- **Evidence**: metadata.md abstract, Results.
- **Implication**: The projected future burden motivates early diagnosis and targeted intervention planning.

## Gaps

### G01: Incidence-specific decomposition was underrepresented in prior GBD reporting
- **Statement**: The abstract states that previous GBD studies primarily focused on prevalence and mortality, leaving historical incidence trends and future incidence projections less directly characterized.
- **Caused by**: O02.
- **Existing attempts**: Previous GBD studies and original GBD datasets/supplementary documents.
- **Why they fail**: Not available from provided input beyond the abstract's statement that the needed incidence-focused analytical perspectives were not provided.

### G02: Full reproducibility details are missing from the provided input
- **Statement**: The abstract names the data source and APC/BAPC models but does not provide equations, priors, software, code, uncertainty intervals, age groups, or preprocessing details.
- **Caused by**: Abstract-only availability.
- **Existing attempts**: Not available from provided input.
- **Why they fail**: Not available from provided input.

## Key Insight

- **Insight**: Applying APC to GBD 2021 incidence estimates and BAPC to future incidence forecasting can separate age, period, and birth-cohort perspectives while producing forward-looking disease-burden projections.
- **Derived from**: O02, O03, O05.
- **Enables**: Historical trend analysis by country/region/demography and future planning for Alzheimer disease and other dementia burden.

## Assumptions

- A1: GBD 2021 estimates are suitable for cross-country and regional incidence analysis.
- A2: APC and BAPC are appropriate for the incidence-trend and projection tasks described in the abstract.
- A3: Detailed model settings, uncertainty estimates, and sensitivity analyses are not available from provided input.
